Department of Health and Human Services implementation guidance for syringe services programs July 2010 by United States. Department of Health and Human Services. et al.
Department of Health and Human Services  
Implementation Guidance for 





The purpose of this document is to provide implementation guidance for the Department 
of Health and Human Services (HHS) programs interested in implementing syringe 
services programs (SSPs) for injection drug users (IDUs) with Fiscal Year (FY) 2010 
appropriated dollars.  The term SSP is inclusive of syringe access, disposal, and needle 
exchange programs, as well as referral and linkage to HIV prevention services, substance 
abuse treatment, and medical and mental health care.   
 
In December 2009, the President signed the Consolidated Appropriations Act, 2010, 
which modified the ban on use of Federal funds for needle exchange programs (also 
known as syringe exchange programs [SEPs]) for many HHS programs.  However,   
authorizations for some HHS programs may still contain partial or complete bans on the 
use of funds for needle exchange programs, and grantees should contact their relevant 
program office for additional information.  The modified provision prohibits the use of 
funds for SEPs in any location that local public health or law enforcement agencies 
determine to be inappropriate.  
 
HHS is committed to working with grantees and partners to obtain input on long-term, 
comprehensive SSP guidance (including SEPs) for implementing this public health 
strategy to reduce the spread of HIV and other infections.  HHS is also committed to 
working with grantees to develop and implement appropriate monitoring and evaluation 
plans for SSP activities.   
 
Guiding Principles for Using HHS funding for SSPs:   
• Programs that use Federal funding for SSPs should adhere to state and local laws, 
regulations, and requirements related to such programs or services. 
• SSPs must be implemented as part of a comprehensive service program that 
includes, as appropriate, linkage and referral to substance abuse prevention and 
treatment services, mental health, and other support services. 
• To minimize duplication of effort, HHS grantees should coordinate and 
collaborate with other agencies, organizations, and providers involved in SSPs, 
substance abuse prevention and treatment, and HIV prevention activities. 
• Redirected funds for SSPs should ensure that referral and linkage to HIV or 
substance abuse prevention and treatment are maintained, and no funds should be 
redirected from substance abuse treatment programs to support SSPs.  
• SSPs are subject to the terms and conditions incorporated or referenced in the 
grantee’s current cooperative agreement or grants. 
• Grantees will annually certify that they will comply with language included in the 
Consolidated Appropriations Act, 2010, which states, “None of the funds 
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contained in this Act may be used to distribute any needle or syringe for the 
purpose of preventing the spread of blood-borne pathogens in any location that 
has been determined by the local public health or local law enforcement 
authorities to be inappropriate for such distribution.”  
o This certification statement should be signed by an authorized official 
(e.g., AIDS program director or SAMHSA grantee official responsible for 
signing on behalf of the applicant organization). 
o Funded grantees must, in turn, have documentation that local law 
enforcement and local public health authorities have agreed upon the 
location for the operation of the SSPs. 
o Copies of this documentation must be made available upon request by 
HHS and others, as appropriate (e.g. the Office of Inspector General, and 
the Government Accountability Office). 
• Funds may be used for, but are not limited to, the following: 
o Personnel (e.g.,  program staff, as well as staff for monitoring, evaluation, 
and quality assurance); 
o SSP equipment (e.g., syringes, syringe disposal bins, cotton, and 
condoms); 
o Syringe disposal services (e.g., contract or other arrangement for disposal 
of biohazardous material); 
o Educational materials, including information about HIV prevention and 
care services, mental health and substance abuse treatment;  
o Communication and marketing activities; and 
o Evaluation activities. 
 
The attached Certification Statement must be signed by all HHS grantees proposing to 
use funds for SSPs, and must be resubmitted annually along with any request for 




Attachment - To be submitted on Official Letterhead - 
 
 
Annual Certification Statement   
 
I certify that the applicable state or local health department and state or local law 
enforcement authorities have been consulted and that the proposed use of funds is 
consistent with the following provision of law: 
 
“None of the funds contained in this Act may be used to distribute any needle or syringe 
for the purpose of preventing the spread of blood-borne pathogens in any location that 
has been determined by the local public health or local law enforcement authorities to be 
inappropriate for such distribution.”  
 
In addition, I certify that programs within my state or local jurisdiction proposing the 
implementation of syringe services programs (SSPs) and those that are currently 
implementing SSPs have provided me with documentation that they are in accordance 














CDC Specific Guidance for Health Departments Implementing SSPs 
 
This guidance was developed in accordance with HHS’s Implementation Guidance for 
Syringe Services Programs (SSPs)  
 
Applicable cooperative agreements 
 
Only FY 2010 funds provided under PS10-1001 (HIV Prevention Projects) and PS10-
1002 (HIV Prevention Projects for the Pacific Islands) may be used to support SSPs.  
Please refer to those Funding Opportunity Announcements (FOAs) for guidance on 
submission of programmatic and budget requirements.  Funds from PS06-618 (HIV 
Prevention Projects for Young Men of Color Who Have Sex with Men and Young 
Transgendered Persons of Color); PS04-064 (HIV Prevention Projects for Community-
Based Organizations); PS07-768 (Expanded and Integrated Human Immunodeficiency 
Virus [HIV] Testing for Populations Disproportionately Affected by HIV, Primarily 
African Americans); and PS08-803 (HIV Prevention Projects for Community Based 
Organizations in Puerto Rico and the U.S. Virgin Islands) may not use Federal funds for 
implementing SSPs.  However, grantees funded under these cooperative agreements may 
collaborate with state or local health departments to implement SSPs in conjunction with 
state/local or other federally funded programs. Absent changes in law, in subsequent 
years, funds from some other cooperative agreements may become eligible to support 
SSPs, and additional guidance will be provided.  
 
Participation in SSPs is optional under these FOAs.  CDC does not anticipate receiving 
additional targeted resources to fund SSPs during FY 2010.  Therefore, all requests 
should be for redirection of existing funding.    
 
Process for Programs to Use Current Cooperative Agreement Funding for SSPs 
 
Grantees should contact their HIV prevention project officer to discuss their program 
plans before submitting plans or revised budgets to the CDC Procurement and Grants 
Office (PGO).  Grantees should be prepared to discuss a proposed budget and budget 
justification, as well as which programs will be affected by the proposed budget 
redirection.  A request for prior approval and a revised Notice of Award must be signed 
by the PGO Grants Management Officer before the grantee can redirect funding for SSPs. 
 
Also note:  
 
• If state and local health departments plan to implement SSPs and have identified 
injection drug users (IDUs) or people who share injection equipment as a priority 
population in their Community Planning Comprehensive HIV Prevention Plan, 
they should amend the activities/interventions section therein to include SSPs as a 







CDC Specific Guidance (continued) 
 
• A new Community Planning Group (CPG) concurrence letter should be submitted 
with the revised HIV Prevention Plan.  Using resources for SSPs that serve IDUs, 
including persons who share injection equipment should be supported by the 
jurisdiction’s epidemiologic profile.  
 
• CDC will work in partnership with jurisdictions to determine the appropriate 
process measures to capture for SSPs.  It is anticipated that basic metrics (e.g., 
number of syringes distributed, number of disposals, referrals to drug treatment, 
etc.) will be collected.  CDC will more fully address monitoring and evaluation 
activities based on expert input provided at the upcoming consultation on SSPs. 
 
• The grantee must keep documentation on file indicating that local law 
enforcement and local public health authorities have agreed to locations identified 
for SSP operation. 
 
Checklist for Submission of Documents to CDC 
 
CDC will implement a streamlined process for consideration of SSPs.  Grantees should 
submit the following to PGO for budget redirection:  
 
• Description of proposed model(s) and plans; 
• Timeline for implementation (for grantees without prior experience with SSPs, 
this should include development of SSP protocols and guidelines, staff training, 
and other preparatory activities); 
• Copy of existing SSP protocols or guidelines, if available;  
• Budget, budget justification, and proposed activities, including a plan for disposal 
of injection equipment;  
• Letter from the CPG that describes prioritized populations and activities for IDUs 
or people who share injection equipment, which SSPs will address; 
• Description of current training and technical assistance needs;  
• List of SSPs to be supported with Federal funds in their jurisdictions; and  
• Signed statement (i.e., Annual Certification) that the grantee will comply with the 
language in the Consolidated Appropriations Act, 2010.  
 
If capacity building assistance is needed, grantees should contact their HIV prevention 
project officer to discuss specific needs or to submit training requests.  Requests should 








SAMHSA Specific Guidance for Minority HIV/AIDS Programs 
Implementing SSPs 
 
This guidance was developed in accordance with HHS’s Implementation Guidance for 
Syringe Services Programs (SSPs)  
 
Applicable cooperative agreements and grants 
 
Only grants funded under the Minority HIV/AIDS program (SP-08-001) and the TCE-
HIV program (TI-08-006, TI-07-004, and TI-06-010) can support SSP services in FY 
2010.  Participation in SSPs is optional under these RFAs.  SAMHSA anticipates no new 
funding targeted to SSPs in FY 2010.  Therefore, all requests should be for redirection of 
existing funding.  In subsequent years, grantees will have greater flexibility to support 
SSP services. 
 
Grantees planning to complement field staff with SSPs are required to assess the 
effectiveness of SSP activities in referring individuals to substance abuse prevention and 
treatment services and in reducing HIV risk behaviors.  All substance abuse prevention 
and treatment grantees targeting individuals at risk for HIV must continue to satisfy 
statutory mandates and existing reporting requirements through use of approved 
methodologies and approaches.  In addition, any adverse or potentially disruptive 
incidents related to the SSP must be reported when they occur, including community 
opposition, law enforcement encounters, needle stick injuries, theft of supplies, potential 
legal action, among others.  Monthly and quarterly reports will be required that delineate 
the number of participants enrolled; number and types of services directly provided or 
provided by referrals, including substance abuse treatment; HIV counseling and testing; 
medical and mental health care services; and supportive services.  Grantees must also 
report on specific outcomes, including any changes in risk behaviors or readiness to 
change (denoted by explicit measures) among program participants.  
 
Grantees will be required to annually certify that they will comply with the language in 
the Consolidated Appropriations Act, 2010, which states:  “None of the funds  contained  
in this Act may be used to distribute any needle or syringe for the purpose of preventing 
the spread of blood-borne pathogens in any location that has been determined by the 
local public health or local law enforcement authorities to be inappropriate for such 
distribution.”  
 
Documentation must be maintained on file by the grantee indicating that local law 
enforcement and local public health authorities have agreed to locations identified for 
SSP operation. 
 
If you have any questions, contact your SAMHSA Project Officer.   
 
 
